The Effectiveness of a New Topical Formulation Containing GSH-C4 and Hyaluronic Acid in Seborrheic Dermatitis: Preliminary Results of an Exploratory Pilot Study.
Elena CampioneSara MazzilliCaterina LannaTerenzio CosioVincenzo PalumboGaia Maria CesaroniFlavia LozziLaura DiluvioLuca BianchiPublished in: Clinical, cosmetic and investigational dermatology (2019)
The results of our pilot study confirm the efficacy and tolerability of this new topical formulation in a real-life assessment and patients showed strong adherence to therapy. These promising results - still to be confirmed on a larger number of patients - emphasize the potential SEB has in controlling the chronic inflammation of seborrheic dermatitis.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- hyaluronic acid
- randomized controlled trial
- oxidative stress
- drug delivery
- prognostic factors
- type diabetes
- adipose tissue
- stem cells
- patient reported outcomes
- insulin resistance
- climate change
- bone marrow
- atopic dermatitis
- glycemic control
- replacement therapy
- study protocol